miR-337 regulates the proliferation and invasion in pancreatic ductal adenocarcinoma by targeting HOXB7

Diagnostic Pathology

Guoqiang Zhao¹  Xiaonan Chen¹  Wenqiao Zang¹  Yuanyuan Wang¹  Yuwen Du¹  Junwen Huang¹  Hong Leng²  Rui Zhang³ 

[1] College of Basic Medical Sciences, Zhengzhou University, No.100 Kexue Road, Zhengzhou 450001, China;Department of immunology and pathogen biology, Luoyang Vocational & Technical College, Luoyang, China;Department of emergency, the First Affiliated Hospital of Zhengzhou University, No.1 Jianshe Road, Zhengzhou 450052, Henan, China

关键词: miR-337;    HOXB7;    Pancreatic ductal adenocarcinoma (PDAC);   

Others  :  1149906
DOI  :  10.1186/s13000-014-0171-2

 received in 2014-07-21, accepted in 2014-08-19,  发布年份 2014

【 摘 要 】

Background

miRNAs are involved in coordinating a variety of cellular processes by regulating their target genes. Aberrant expression of miRNAs is correlated with various cancers. Previous studies have shown that miR-337 is significantly down-regulated in pancreatic ductal adenocarcinoma (PDAC) and that its expression is negatively correlated to the expression of HOXB7. Both miR-337 and HOXB7 are associated with the prognosis of PDAC patients. The purpose of this study was to identify the molecular mechanisms by which miR-337 acts as a tumor suppressor in PDAC.

Methods

Synthetic miR-337 mimics were transfected into PANC-1 and As-PC-1 cells using Lipofectamine¿ 2000. The expression of HOXB7 protein was analyzed by Western blot. Luciferase reporter plasmids were constructed to confirm that HOXB7 3?UTR was the target of miR-337. The effect of miR-337 on cell proliferation was evaluated by CCK8 assay and colony formation assay, and cell invasion was evaluated by wound healing assay and transwell assay.

Results

Western blot and luciferase activity assays identified HOXB7 as the target of miR-337. A CCK-8 assay showed the absorbance of cells transfected with miR-337 mimics to be less than that of control cells, and that the number of cell clones was significantly decreased by miR-337 expression. A wound healing assay showed the invasion rate of cells transfected with miR-337 mimics at 36 h to be markedly lower than in controls. The average number of cells penetrating the Matrigel was significantly lower than the controls.

Conclusion

These findings suggest that miR-337 targets HOXB7 and effects significant suppression of PDAC cell proliferation and invasion.

Virtual Slides

The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/13000_2014_171 webcite

【 授权许可】

   
2014 Zhang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Zamore PD, Haley B: The big world of small RNAs. Science 2005, 309(5740):1519-1524.
• [2]Mattick JS, Makunin IV: Non-coding RNA. Hum Mol Genet 2006, 15(Spec No 1):R17-29.
• [3]Hwang HW, Mendell JT: MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006, 94(6):776-780.
• [4]Moreno-Moya JM, Vilella F, Simón C: MicroRNA: key gene expression regulators. Fertil Steril 2014, 101(6):1516-1523.
• [5]Tüfekci KU, Meuwissen RL, Genç S: The role of microRNAs in biological processes. Methods Mol Biol 2014, 1107:15-31.
• [6]Wan HY, Guo LM, Liu T, Liu M, Li X, Tang H: Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer 2010, 9:16.
• [7]Booton R, Lindsay MA: Emerging Role of MicroRNAs and Long Noncoding RNAs in Respiratory Disease. Chest 2014, 146(1):193-204.
• [8]Ventura A, Jacks T: MicroRNAs and cancer: short RNAs go a long way. Cell 2009, 136:586-591.
• [9]Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009, 10:704-714.
• [10]Li XY, Luo QF, Wei CK, Li DF, Li J, Fang L: MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer. Int J Clin Exp Med 2014, 7(1):32-40.
• [11]Wan L, Zhang L, Fan K, Wang J: MiR-27b targets LIMK1 to inhibit growth and invasion of NSCLC cells. Mol Cell Biochem 2014, 390(1¿2):85-91.
• [12]Ma L, Teruya-Feldstein J, Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449(7163):682-688.
• [13]Zhao H, Wang Y, Yang L, Jiang R, Li W: MiR-25 promotes gastric cancer cells growth and motility by targeting RECK. Mol Cell Biochem 2014, 385(1¿2):207-213.
• [14]Hayashida T, Takahashi F, Chiba N, Brachtel E, Takahashi M, Godin-Heymann N, Gross KW, Vivanco MD, Wijendran V, Shioda T, Sgroi D, Donahoe PK, Maheswaran S: HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis. Proc Natl Acad Sci U S A 2010, 107(3):1100-1105.
• [15]Hong JH, Lee JK, Park JJ, Lee NW, Lee KW, Na JY: Expression pattern of the class I homeobox genes in ovarian carcinoma. J Gynecol Oncol 2010, 21(1):29-37.
• [16]Shimoda M, Takahashi M, Yoshimoto T, Kono T, Ikai I, Kubo H: A homeobox protein, prox1, is involved in the differentiation, proliferation, and prognosis in hepatocellular carcinoma. Clin Cancer Res 2006, 12(20 Pt 1):6005-6011.
• [17]Petrini M, Felicetti F, Bottero L, Errico MC, Morsilli O, Boe A, De Feo A, Carè A: HOXB1 restored expression promotes apoptosis and differentiation in the HL60 leukemic cell line. Cancer Cell Int 2013, 13(1):101.
• [18]Gray S, Pandha HS, Michael A, Middleton G, Morgan R: HOX genes in pancreatic development and cancer. JOP 2011, 12(3):216-219.
• [19]Xie X, Zhang SS, Wen J, Yang H, Luo KJ, Yang F, Hu Y, Fu JH: Prognostic value of HOXB7 mRNA expression in human oesophageal squamous cell cancer. Biomarkers 2013, 18(4):297-303.
• [20]Nguyen Kovochich A, Arensman M, Lay AR, Rao NP, Donahue T, Li X, French SW, Dawson DW: HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma. Cancer 2013, 119(3):529-39.
• [21]Zhang R, Zheng S, Du Y, Wang Y, Zang W, Zhao G: Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patients. Diagn Pathol 2014, 9:61.
• [22]Garin E, Lemieux M, Coulombe Y, Robinson GW, Jeannotte L: Stromal Hoxa5 function controls the growth and differentiation of mammary alveolar epithelium. Dev Dyn 2006, 235(7):1858-1871.
• [23]Lu Z, Hardt J, Kim JJ: Global analysis of genes regulated by HOXA10 in decidualization reveals a role in cell proliferation. Mol Hum Reprod 2008, 14(6):357-366.
• [24]De Souza Setubal Destro MF, Bitu CC, Zecchin KG, Graner E, Lopes MA, Kowalski LP, Coletta RD: Overexpression of HOXB7 homeobox gene in oral cancer induces cellular proliferation and is associated with poor prognosis. Int J Oncol 2010, 36(1):141-149.
• [25]Chen H, Lee JS, Liang X, Zhang H, Zhu T, Zhang Z, Taylor ME, Zahnow C, Feigenbaum L, Rein A, Sukumar S: Hoxb7 inhibits transgenic HER-2/ neu-induced mouse mammary tumor onset but promotes progression and lung metastasis. Cancer Res 2008, 68(10):3637-3644.
• [26]Yuan W, Zhang X, Xu Y, Li S, Hu Y, Wu S: Role of HOXB7 in regulation of progression and metastasis of human lung adenocarcinoma. Mol Carcinog 2014, 53(1):49-57.
• [27]Liao WT, Jiang D, Yuan J, Cui YM, Shi XW, Chen CM, Bian XW, Deng YJ, Ding YQ: HOXB7 as a prognostic factor and mediator of colorectal cancer progression. Clin Cancer Res 2011, 17(11):3569-3578.
• [28]Carthew RW: Gene regulation by microRNAs. Curr Opin Genet Dev 2006, 16(2):203-208.
• [29]Kim SY, Lee YH, Bae YS: MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting ? subunit of protein kinase CKII in human colorectal cancer cells. Biochem Biophys Res Commun 2012, 429(3¿4):173-179.
• [30]Hauser S, Wulfken LM, Holdenrieder S, Moritz R, Ohlmann CH, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel G, von Ruecker A, Müller SC, Ellinger J: Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma. Cancer Epidemiol 2012, 36(4):391-394.
• [31]Kim J, Jang SG, Kwon SY, Park YS, Kang HS, Green JE, Kim HK, Ro J: MicroRNA Signature for HER2-positive Breast and Gastric Cancer. Anticancer Res 2014, 34(7):3807-10.
• [32]Wu C, Wang C, Guan X, Liu Y, Li D, Zhou X, Zhang Y, Chen X, Wang J, Zen K, Zhang CY, Zhang C: Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma. PLoS One 2014, 9(3):e92292.
• [33]Du L, Subauste MC, DeSevo C, Zhao Z, Baker M, Borkowski R, Schageman JJ, Greer R, Yang CR, Suraokar M, Wistuba II, Gazdar AF, Minna JD, Pertsemlidis A: miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers. PLoS One 2012, 7(6):e39167.
• [34]Shih KK, Qin LX, Tanner EJ, Zhou Q, Bisogna M, Dao F, Olvera N, Viale A, Barakat RR, Levine DA: A microRNA survival signature (MiSS) for advanced ovarian cancer. Gynecol Oncol 2011, 121(3):444-50.
• [35]Wang Z, Wang J, Yang Y, Hao B, Wang R, Li Y, Wu Q: Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer. J Exp Clin Cancer Res 2013, 32(1):76.